Sanofi to invest USD 75 million in a new manufacturing facility in Vietnam

Sanofi (EURONEXT: SAN and NYSE: SNY) announces today the official launch of a construction project for a new manufacturing facility in the Saigon High Tech Park – Ho Chi Minh City, during a ceremony in the presence of Christopher A. Viehbacher, Chief Executive Officer of Sanofi. The new state-of-the-art plant will expand Sanofi’s manufacturing capacity in Vietnam to meet the fast growing demand of the Vietnamese pharmaceutical market and will serve as an export platform to ASEAN(*) countries.

The investment in this new plant will amount to USD 75 million and will constitute Sanofi’s largest investment in Vietnam to date. With an initial capacity of 90 million units per year – and a possible extension up to 150 million units – the facility will produce high-quality pharmaceuticals and consumer healthcare products. The plant is scheduled to be fully operational by the end of 2015 and will join Sanofi’s existing network of 40 manufacturing sites in Emerging Markets.

“This new production and development center is the largest investment ever made by Sanofi in Vietnam and illustrates our commitment to bringing high quality medicines to a broader population in Vietnam”, said Christopher A. Viehbacher, Chief Executive Officer of Sanofi. “Sanofi has been present in Vietnam for more than 50 years and has built the number 1 position in one of the most dynamic South East Asian countries. This new investment will contribute to further strengthen Sanofi’s leadership position in Emerging Markets”.

(*) ASEAN: Association of South East Asian Nations